STAT3 and breast carcinoma: For example, Bcl-xL, MCL1, and survivin are STAT3 target genes [67] that are downregulated in breast cancer cell lines treated with the small molecule hydroxamic acid–based and benzoic acid–based STAT3 inhibitors [68].